遺伝性網膜疾患の世界市場レポート 2025年

遺伝性網膜疾患市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.5％で174億2,000万米ドルに成長します。予測期間においては、CRISPRの利用拡大、個別化治療の登場、再生医療の進歩、患者アドボカシーの拡大、患者のQOL向上への注力などが成長の原動力になるとみられます。予測期間における主な動向としては、オプトジェネティクス技術の発展、人工網膜インプラントの開発、デジタルヘルスプラットフォームの拡大、疾患モデリングにおける人工知能の統合、治療計画における人工知能の利用などが挙げられます。

黄斑変性症の有病率の増加は、遺伝性網膜疾患市場の成長を促進すると予想されます。黄斑変性症は、黄斑を損傷する加齢に関連した眼疾患で、中心視力の低下や、読書や顔の認識などの活動に課題が生じます。黄斑変性症の罹患率の上昇は、人口の高齢化、平均寿命の延長、喫煙や栄養不良などのライフスタイルの選択といった要因がリスクを高めています。遺伝性網膜疾患治療は、網膜変性の遺伝的原因を標的とし、疾患の進行を遅らせたり、失われた視力を回復させたり、網膜のさらなる損傷を予防したりする治療法です。これにより、加齢黄斑変性症や遺伝性黄斑変性症に罹患した人々の視覚的転帰と生活の質が最終的に改善されます。例えば、2024年2月、カナダ眼科学会は、加齢黄斑変性（AMD）による視力低下を患う55歳以上のカナダ人は250万人に上ると報告しました。黄斑変性症の有病率の増加は、遺伝性網膜疾患分野の市場成長を促進しています。

遺伝性網膜疾患市場の企業は、これらの疾患に関連する幅広い遺伝的変異に対処するため、変異診断的遺伝子治療などの革新的治療に注力しています。変異診断的遺伝子治療は、特定の変異ではなく、一般的な遺伝メカニズムや経路を標的とするため、より広範な遺伝性疾患に適用できます。例えば、米国を拠点とするバイオテクノロジー企業であるナノスコープ・セラピューティクス社は、2024年3月、同社の主要プログラムであるMCO-010の臨床試験で良好な結果が得られたと発表し、進行性網膜色素変性症による重度の永続的視力低下を有する患者の視力改善を実証しました。MCO-010は、主要評価項目および主要な副次的評価項目を統計学的に有意に達成し、重篤な有害事象は認められませんでした。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界遺伝性網膜疾患PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の遺伝性網膜疾患市場：成長率分析
• 世界の遺伝性網膜疾患市場の実績：規模と成長, 2019-2024
• 世界の遺伝性網膜疾患市場の予測：規模と成長, 2024-2029, 2034F
• 世界遺伝性網膜疾患総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の遺伝性網膜疾患市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断
• 治療
• 世界の遺伝性網膜疾患市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 網膜色素変性症
• 脈絡膜ジストロフィー
• シュタルガルト病
• 円錐体ジストロフィー
• レーバー先天性黒内障
• その他の病気
• 世界の遺伝性網膜疾患市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小売売上高
• 直接入札
• 世界の遺伝性網膜疾患市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 外来手術センター
• 在宅ヘルスケア
• その他のエンドユーザー
• 世界の遺伝性網膜疾患市場、診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子検査（遺伝子スクリーニング）
• 網膜画像検査（眼底写真、光干渉断層撮影（OCT））
• 電気生理学的検査（網膜電図検査）
• 視野検査
• 眼底自己蛍光イメージング
• 世界の遺伝性網膜疾患市場、治療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子治療
• 幹細胞療法
• 網膜プロテーゼ（人工網膜）
• 薬理学的治療（遺伝子編集、網膜薬）
• 光受容体救済療法

第7章 地域別・国別分析

• 世界の遺伝性網膜疾患市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の遺伝性網膜疾患市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 遺伝性網膜疾患市場：競合情勢
• 遺伝性網膜疾患市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Vertex Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ionis Pharmaceuticals Inc.
• Invitae Corporation
• Spark Therapeutics
• Aldeyra Therapeutics
• Regenxbio Inc.
• IVERIC bio
• MeiraGTx Limited
• Ocugen Inc.
• Coave Therapeutics
• Bionic Vision Technologies
• GenSight Biologics SA
• LKC Technologies Inc.
• Sparing Vision
• ProQR Therapeutics NV
• Endogena Therapeutics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 遺伝性網膜疾患市場2029：新たな機会を提供する国
• 遺伝性網膜疾患市場2029：新たな機会を提供するセグメント
• 遺伝性網膜疾患市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Inherited retinal diseases are a group of rare genetic disorders caused by mutations in specific genes, primarily affecting the retina, the light-sensitive tissue at the back of the eye. These diseases are often challenging to treat due to their genetic complexity, but advancements in gene therapy and other innovative technologies offer promising treatment options.

The main approaches for treating inherited retinal diseases include diagnosis and therapy. Diagnosis utilizes advanced technologies such as genetic testing, optical coherence tomography, and fundus imaging to identify these diseases and determine their genetic causes. These treatments address various conditions such as retinitis pigmentosa, choroideremia, Stargardt disease, cone-rod dystrophy, Leber congenital amaurosis, and others. They are distributed through channels such as retail sales and direct tenders, and are used by various end users including hospitals, specialty clinics, ambulatory surgical centers, home healthcare settings, and others.

The inherited retinal disease market research report is one of a series of new reports from The Business Research Company that provides inherited retinal disease market statistics, including inherited retinal disease industry global market size, regional shares, competitors with a inherited retinal disease market share, detailed inherited retinal disease market segments, market trends and opportunities, and any further data you may need to thrive in the inherited retinal disease industry. This inherited retinal disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inherited retinal disease market size has grown strongly in recent years. It will grow from $11.56 billion in 2024 to $12.58 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to the adoption of gene therapy, regulatory incentives, an increase in patient registries, the rise in clinical trials, and the growing focus on patient-centric solutions.

The inherited retinal disease market size is expected to see strong growth in the next few years. It will grow to $17.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. In the forecast period, growth is expected to be driven by the increased use of CRISPR, the emergence of personalized treatments, advancements in regenerative medicine, the growth of patient advocacy, and a focus on improving patients' quality of life. Key trends in the forecast period include advancements in optogenetics technology, the development of artificial retina implants, the expansion of digital health platforms, the integration of artificial intelligence in disease modeling, and the use of artificial intelligence in treatment planning.

The increasing prevalence of macular degeneration is expected to drive the growth of the inherited retinal disease market. Macular degeneration, an age-related eye condition that damages the macula, results in central vision loss and challenges with activities such as reading or recognizing faces. The rising incidence of macular degeneration is driven by factors such as aging populations, longer life expectancy, and lifestyle choices such as smoking and poor nutrition, which elevate the risk. Inherited retinal disease treatments target the genetic causes of retinal degeneration, offering therapies that can slow disease progression, restore lost vision, or prevent further damage to the retina. This ultimately improves visual outcomes and quality of life for those affected by age-related or inherited forms of macular degeneration. For example, in February 2024, the Canadian Ophthalmological Society reported that 2.5 million Canadians over the age of 55 suffer from vision loss due to age-related macular degeneration (AMD). The increasing prevalence of macular degeneration is thus fueling market growth in the inherited retinal disease sector.

Companies in the inherited retinal disease market are focusing on innovative treatments, such as mutation-agnostic gene therapy, to address a broader range of genetic variations associated with these conditions. Mutation-agnostic gene therapy targets general genetic mechanisms or pathways rather than specific mutations, making it applicable to a wider variety of genetic disorders. For example, in March 2024, Nanoscope Therapeutics Inc., a U.S.-based biotechnology company, announced positive results from a clinical trial of its lead program, MCO-010, which demonstrated vision improvements for patients with severe, permanent vision loss from advanced retinitis pigmentosa. MCO-010 achieved both primary and key secondary endpoints with statistical significance and no serious adverse events.

In October 2024, Ocuphire Pharma, Inc., a U.S.-based biopharmaceutical company, acquired Opus Genetics Inc. for an undisclosed amount. This acquisition aimed to strengthen Ocuphire Pharma's gene therapy portfolio and expedite the development of treatments for inherited retinal diseases (IRDs) by integrating Opus Genetics Inc.'s innovative gene therapies for rare retinal conditions. Opus Genetics Inc. is a clinical-stage company focused on advancing gene therapies for inherited retinal diseases.

Major players in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inherited retinal disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the inherited retinal disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The inherited retinal disease market includes revenues earned by entities by providing services such as ophthalmic tests, optic nerve imaging, and electrophysiological tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inherited Retinal Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inherited retinal disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inherited retinal disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The inherited retinal disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diagnosis; Therapy
• 2) By Disease Type: Retinitis Pigmentosa; Choroideremia; Stargardt Disease; Cone-rode Dystrophy; Leber Congenital Amaurosis; Other Diseases
• 3) By Distribution Channel: Retail Sales; Direct Tender
• 4) By End Users: Hospitals; Speciality Clinics; Ambulatory Surgical Centres; Home Healthcare; Other End Users

Subsegments;

• 1) By Diagnosis: Genetic Testing (Genetic Screening); Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)); Electrophysiological Testing (Electroretinography); Visual Field Testing; Fundus Autofluorescence Imaging
• 2) By Therapy: Gene Therapy; Stem Cell Therapy; Retinal Prosthesis (Artificial Retina); Pharmacological Therapy (Gene Editing, Retinal Drugs); Photoreceptor Rescue Therapy
• Companies Mentioned: Johnson & Johnson; Novartis AG; Astellas Pharma Inc.; Biogen Inc.; Vertex Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Inherited Retinal Disease Market Characteristics

3. Inherited Retinal Disease Market Trends And Strategies

4. Inherited Retinal Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Inherited Retinal Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Inherited Retinal Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Inherited Retinal Disease Market Growth Rate Analysis
• 5.4. Global Inherited Retinal Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Inherited Retinal Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Inherited Retinal Disease Total Addressable Market (TAM)

6. Inherited Retinal Disease Market Segmentation

• 6.1. Global Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Therapy
• 6.2. Global Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retinitis Pigmentosa
• Choroideremia
• Stargardt Disease
• Cone-rode Dystrophy
• Leber Congenital Amaurosis
• Other Diseases
• 6.3. Global Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Sales
• Direct Tender
• 6.4. Global Inherited Retinal Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Speciality Clinics
• Ambulatory Surgical Centres
• Home Healthcare
• Other End Users
• 6.5. Global Inherited Retinal Disease Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing (Genetic Screening)
• Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT))
• Electrophysiological Testing (Electroretinography)
• Visual Field Testing
• Fundus Autofluorescence Imaging
• 6.6. Global Inherited Retinal Disease Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Stem Cell Therapy
• Retinal Prosthesis (Artificial Retina)
• Pharmacological Therapy (Gene Editing, Retinal Drugs)
• Photoreceptor Rescue Therapy

7. Inherited Retinal Disease Market Regional And Country Analysis

• 7.1. Global Inherited Retinal Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Inherited Retinal Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inherited Retinal Disease Market

• 8.1. Asia-Pacific Inherited Retinal Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inherited Retinal Disease Market

• 9.1. China Inherited Retinal Disease Market Overview
• 9.2. China Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inherited Retinal Disease Market

• 10.1. India Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inherited Retinal Disease Market

• 11.1. Japan Inherited Retinal Disease Market Overview
• 11.2. Japan Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inherited Retinal Disease Market

• 12.1. Australia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inherited Retinal Disease Market

• 13.1. Indonesia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inherited Retinal Disease Market

• 14.1. South Korea Inherited Retinal Disease Market Overview
• 14.2. South Korea Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inherited Retinal Disease Market

• 15.1. Western Europe Inherited Retinal Disease Market Overview
• 15.2. Western Europe Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inherited Retinal Disease Market

• 16.1. UK Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inherited Retinal Disease Market

• 17.1. Germany Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inherited Retinal Disease Market

• 18.1. France Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inherited Retinal Disease Market

• 19.1. Italy Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inherited Retinal Disease Market

• 20.1. Spain Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inherited Retinal Disease Market

• 21.1. Eastern Europe Inherited Retinal Disease Market Overview
• 21.2. Eastern Europe Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inherited Retinal Disease Market

• 22.1. Russia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inherited Retinal Disease Market

• 23.1. North America Inherited Retinal Disease Market Overview
• 23.2. North America Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inherited Retinal Disease Market

• 24.1. USA Inherited Retinal Disease Market Overview
• 24.2. USA Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inherited Retinal Disease Market

• 25.1. Canada Inherited Retinal Disease Market Overview
• 25.2. Canada Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inherited Retinal Disease Market

• 26.1. South America Inherited Retinal Disease Market Overview
• 26.2. South America Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inherited Retinal Disease Market

• 27.1. Brazil Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inherited Retinal Disease Market

• 28.1. Middle East Inherited Retinal Disease Market Overview
• 28.2. Middle East Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inherited Retinal Disease Market

• 29.1. Africa Inherited Retinal Disease Market Overview
• 29.2. Africa Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inherited Retinal Disease Market Competitive Landscape And Company Profiles

• 30.1. Inherited Retinal Disease Market Competitive Landscape
• 30.2. Inherited Retinal Disease Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Vertex Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Inherited Retinal Disease Market Other Major And Innovative Companies

• 31.1. Ionis Pharmaceuticals Inc.
• 31.2. Invitae Corporation
• 31.3. Spark Therapeutics
• 31.4. Aldeyra Therapeutics
• 31.5. Regenxbio Inc.
• 31.6. IVERIC bio
• 31.7. MeiraGTx Limited
• 31.8. Ocugen Inc.
• 31.9. Coave Therapeutics
• 31.10. Bionic Vision Technologies
• 31.11. GenSight Biologics SA
• 31.12. LKC Technologies Inc.
• 31.13. Sparing Vision
• 31.14. ProQR Therapeutics NV
• 31.15. Endogena Therapeutics

32. Global Inherited Retinal Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inherited Retinal Disease Market

34. Recent Developments In The Inherited Retinal Disease Market

35. Inherited Retinal Disease Market High Potential Countries, Segments and Strategies

• 35.1 Inherited Retinal Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Inherited Retinal Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Inherited Retinal Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer